Krilogy Financial’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Krilogy Financial’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9	Closed	–	–	796
2018 Q3	$0	Buy	+9	New	+$40	﹤0.01%	848
2018 Q2	–	Sell	-19	Closed	–	–	742
2018 Q1	$0	Hold	19	–	–	﹤0.01%	832
2017 Q4	$0	Sell	19 -8	-30%	-$13	﹤0.01%	865
2017 Q3	$0	Sell	27 -9	-25%	-$31	﹤0.01%	866
2017 Q2	$0	Sell	36 -24	-40%	-$87	﹤0.01%	799
2017 Q1	$0	Hold	60	–	–	﹤0.01%	730
2016 Q4	$0	Hold	60	–	–	﹤0.01%	781
2016 Q3	$0	Hold	60	–	–	﹤0.01%	798
2016 Q2	$0	Hold	60	–	–	﹤0.01%	776
2016 Q1	$1K	Hold	60	–	–	﹤0.01%	669
2015 Q4	$0	Hold	60	–	–	﹤0.01%	627
2015 Q3	$1K	Buy	+60	New	+$553	﹤0.01%	601

Other funds holding CORV

Westfield Capital Management

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return